GURUFOCUS.COM » STOCK LIST » Energy » Oil & Gas » Core Laboratories Inc (NYSE:CLB) » Definitions » Net Income

Core Laboratories (Core Laboratories) Net Income

: $23.7 Mil (TTM As of Mar. 2023)
View and export this data going back to 1995. Start your Free Trial

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Core Laboratories's Net Income for the three months ended in Mar. 2023 was $2.4 Mil. Its Net Income for the trailing twelve months (TTM) ended in Mar. 2023 was $23.7 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. Core Laboratories's Earnings per Share (Diluted) for the three months ended in Mar. 2023 was $0.05.


Core Laboratories Net Income Historical Data

The historical data trend for Core Laboratories's Net Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Core Laboratories Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Income
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 79.53 101.98 -97.64 19.73 19.45

Core Laboratories Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Net Income Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.89 7.07 7.52 6.75 2.37

Core Laboratories Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

Core Laboratories's Net Income for the fiscal year that ended in Dec. 2022 is calculated as

Net Income(A: Dec. 2022 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=29.954+-10.296+0+-0.205
=19.5

Core Laboratories's Net Income for the quarter that ended in Mar. 2023 is calculated as

Net Income(Q: Mar. 2023 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=3.052+-0.61+0+-0.069
=2.4

Net Income for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $23.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Core Laboratories  (NYSE:CLB) Net Income Explanation

Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

Core Laboratories's Earnings per Share (Diluted) (EPS) for the quarter that ended in Mar. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Core Laboratories Net Income Related Terms

Thank you for viewing the detailed overview of Core Laboratories's Net Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Core Laboratories (Core Laboratories) Business Description

Traded in Other Exchanges
N/A
Address
6316 Windfern Road, Houston, TX, USA, 77040
Core Laboratories is the premier provider of reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.
Executives
Katherine Murray director 6316 WINDFERN ROAD, HOUSTON TX 77040
Mark Damian Tattoli officer: SVP, Gen Counsel & Secretary C/O CORE LABORATORIES LP, 6316 WINDFERN ROAD, HOUSTON TX 77040
Kwaku Temeng director C/O CORE LABORATORIES LP, 2216 SHERIDAN STREET, HOUSTON TX 77002
Gwendolyn Schreffler officer: SVP C/O CORE LABORATORIES LP, 6316 WINDFERN ROAD, HOUSTON TX 77040
Harvey Robert Klingensmith director P.O. BOX 131144, HOUSTON TX 77219-1114
Van Dijken Eeuwijk Monique director P.O. BOX 129, BILTHOVEN P7 3720 AC
Jan Willem Sodderland director DUINDISTEL 89, NOORDWIJK P7 2202 DE
Goldman Sachs Group Inc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Goldman Sachs & Co. Llc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Lawrence Bruno officer: President 6316 WINDFERN ROAD, HOUSTON TX 77040
Mark F Elvig officer: VP, Counsel & Secretary 6316 WINDFERN, HOUSTON TX 77040
Gregory Barry Barnett director 853 MILWAUKEE STREET, DENVER CO 80206
Kevin Daniels officer: CAO & Treasurer 6316 WINDFERN ROAD, HOUSTON TX 77040
Michael Straughen director 68 RUBISLAW DEN NORTH, ABERDEEN X0 AB15 4AN
Martha Z. Carnes director 6316 WINDFERN ROAD, HOUSTON TX 77040